Lifitegrast
| CAS No. | 1025967-78-5 |
|---|---|
| MDL No. | MFCD28502439 |
| MF | C29H24Cl2N2O7S |
| MW | 615.50 |
| InChI Key | JFOZKMSJYSPYLN-QHCPKHFHSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Lifitegrast is an N-acyl-L-alpha-amino acid formed by the condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. It is used to treat keratoconjunctivitis sicca (dry eye syndrome) and functions as an anti-inflammatory drug and lymphocyte function-associated antigen-1 antagonist. It is a L-phenylalanine derivative, a sulfone, an N-acyl-L-alpha-amino acid, a member of isoquinolines, and a member of 1-benzofurans.
| CAS No. | 1025967-78-5 |
|---|---|
| Product Name | Lifitegrast |
Biological Targets
ITGAL·ITGB2
Associated Conditions
eye disease·allergic conjunctivitis·graft versus host disease·dry eye syndrome
* The information provided here is compiled from public sources and is for reference only.